Menú

EMAP
Grup d’Estudis de Medicament en Atenció Primària (EMAP)

RESPONSABLE DEL GRUP
40882722S - Rosa Morros Pedrós - OK retall
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Projectes

Projectes del grup

Safety of Paxlovid among patients with moderate or severe hepatic or renal impairment (C4671047, VAC4EU & SIGMA study)

  • Investigadors principals: Maria Giner Soriano
  • Còdi: 4RNC-0-00182-23
  • Any d’inici: 2023
  • Finançadors: Research Triangle Institute (RTI)

Study protocol for the Teratogenic Drugs Prioritisation (TDP) project combining pre-clinical data with clinical data from ConcePTION data sources (task 7.9)

  • Investigadors principals: Maria Giner Soriano
  • Còdi: 4RNC-0-00095-24
  • Any d’inici: 2024

A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data

  • Investigadors principals: Rosa Morros Pedrós, Maria Giner Soriano
  • Còdi: 4RNC-0-00211-24
  • Any d’inici: 2024
  • Finançadors: European Medicines Agency (EMA)

Antiseizure meDication Exposure and Pregnancy and neonaTal outcomes research (ADEPT). Use of antiepileptics, and feasibility of studies on the association between maternal and paternal exposure to antiepileptics and adverse pregnancy, neonatal and child outcomes

  • Investigadors principals: Rosa Morros Pedrós, Maria Giner Soriano
  • Còdi: 4RNC-0-00239-24
  • Any d’inici: 2024
  • Finançadors: European Medicines Agency (EMA)

Impact of medication adherence on mortality and cardiovascular morbidity: a population-based retrospective cohort study. IMPACT study

  • Investigadors principals: Maria Giner Soriano
  • Còdi: 4R17/020
  • Any d’inici: 2017
  • Finançadors: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)

Patronat

Col·laboradors

Acreditacions